Antisoma (ASM)

[califax]

Antisoma to present at Canaccord Global Growth Conference


Date : 08/06/2010 @ 7:00AM
Source : UK
Regulatory (RNS & others)
Stock : Antisoma (ASM)

http://ih.advfn.com/p.php?pid=nmona&article=43910278&symbol=L^ASM

6 August 2010, London, UK, and Cambridge, MA: Antisoma plc (LSE: ASM; USOTC:
ATSMY) announces that senior executive Dr Michael Boss will present at the 30th
Annual Canaccord Global Growth Conference in Boston on Wednesday August 11 at
1pm local time (6pm BST).

A webcast of the presentation will be available on Antisoma's website
athttp://www.antisoma.com/asm/media/webcast/

For live viewing of the webcast, it is recommended that viewers log on 15
minutes early in order to register and download any necessary software.

Enquiries:
Alison Saville
Senior Marketing and Communications Executive
Antisoma plc
[phone]

Background on Antisoma
Antisoma is a London Stock Exchange-listed biopharmaceutical company that
develops novel products for the treatment of cancer. The Company has operations
in the UK and the US. Please visitwww.antisoma.com for further information about
Antisoma.

This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
All reproduction for further distribution is prohibited.

Source: Antisoma plc via Thomson Reuters ONE